Effects of long‐term treatment with dopamine receptor agonists and antagonists on terminal arbor size

This study demonstrates that pharmacological manipulation of the dopamine (DA) receptors can modulate the size of the axonal tree of substantia nigra pars compacta (SNpc) neurons in mice. Pharmacological blockade or genetic ablation of the D2 receptor (D2R) resulted in sprouting of DA SNpc neurons whereas treatment with a D2 agonist resulted in pruning of the terminal arbor of these neurons. Agents such as cocaine, that indirectly stimulate D2R, also resulted in reduced terminal arbor. Specific D1 agonists or antagonists had no effect on the density of DA terminals in the striatum. We conclude that the D2 receptor has a central role in regulating the size of the terminal arbor of nigrostriatal neurons. These findings have implications relating to the use of dopaminergic agonists in the management of Parkinson's disease and in controlling plasticity following injury, loss or transplantation of DA neurons.

[1]  John W. Thomas,et al.  A 6-Hydroxydopamine-Induced Selective Parkinsonian Rat Model: Further Biochemical and Behavioral Characterization , 1994, Experimental Neurology.

[2]  H. J. G. Gundersen,et al.  The new stereological tools: Disector, fractionator, nucleator and point sampled intercepts and their use in pathological research and diagnosis , 1988, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

[3]  C. Gerfen,et al.  The neostriatal mosaic: II. Patch- and matrix-directed mesostriatal dopaminergic and non-dopaminergic systems , 1987, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[4]  Y. Agid,et al.  Dopaminergic sprouting in the rat striatum after partial lesion of the substantia nigra , 1996, Brain Research.

[5]  H. Gundersen,et al.  Unbiased stereological estimation of the number of neurons in the human hippocampus , 1990, The Journal of comparative neurology.

[6]  A. Levey,et al.  D1 and D2 dopamine receptor mRNA in rat brain. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[7]  Geoffrey A. Donnan,et al.  Activated Macrophages and Microglia Induce Dopaminergic Sprouting in the Injured Striatum and Express Brain-Derived Neurotrophic Factor and Glial Cell Line-Derived Neurotrophic Factor , 1999, The Journal of Neuroscience.

[8]  T. McNeill,et al.  Lesion-induced axon sprouting in the deafferented striatum of adult rat , 1998, Neuroscience Letters.

[9]  I. Creese.  Dopamine receptors explained , 1982, Trends in Neurosciences.

[10]  J. Kebabian,et al.  Multiple receptors for dopamine , 1979, Nature.

[11]  D. German,et al.  Midbrain dopaminergic neurons in the mouse: Computer‐assisted mapping , 1996, The Journal of comparative neurology.

[12]  P. Voorn,et al.  Development of Dopamine - Containing Systems in the CNS , 1992 .

[13]  H. Gundersen,et al.  Unbiased stereological estimation of the total number of neurons in the subdivisions of the rat hippocampus using the optical fractionator , 1991, The Anatomical record.

[14]  C. Gerfen,et al.  Altered striatal function in a mutant mouse lacking D1A dopamine receptors. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[15]  M. Zigmond,et al.  Neurochemical compensation after nigrostriatal bundle injury in an animal model of preclinical parkinsonism. , 1984, Archives of neurology.

[16]  D. Brooks,et al.  A five-year study of the incidence of dyskinesia in patients with early Parkinson's disease who were treated with ropinirole or levodopa. , 2000, The New England journal of medicine.

[17]  T. Robinson,et al.  Compensatory changes in striatal dopamine neurons following recovery from injury induced by 6-OHDA or methamphetamine: a review of evidence from microdialysis studies. , 1990, Canadian journal of psychology.

[18]  J. Fallon,et al.  Catecholamine innervation of the basal forebrain IV. Topography of the dopamine projection to the basal forebrain and neostriatum , 1978, The Journal of comparative neurology.

[19]  Alessandro Usiello,et al.  Distinct functions of the two isoforms of dopamine D2 receptors , 2000, Nature.

[20]  M. Galloway.  Neurochemical interactions of cocaine with dopaminergic systems. , 1988, Trends in pharmacological sciences.

[21]  S. R. Nash,et al.  Dopamine receptors: from structure to function. , 1998, Physiological reviews.

[22]  A. Grace,et al.  Compensations after lesions of central dopaminergic neurons: some clinical and basic implications , 1990, Trends in Neurosciences.

[23]  Irwin J. Kopin,et al.  The Biochemical Basis of Neuropharmacology , 1971, The Yale Journal of Biology and Medicine.

[24]  B J Hoffer,et al.  Clearance and diffusion of locally applied dopamine in normal and 6-hydroxydopamine-lesioned rat striatum. , 1992, The Journal of pharmacology and experimental therapeutics.

[25]  O. Andreassen,et al.  Estimation of the number of somatostatin neurons in the striatum: An in situ hybridization study using the optical fractionator method , 1996, The Journal of comparative neurology.

[26]  A. Ho,et al.  Induction of Interleukin-1 Associated with Compensatory Dopaminergic Sprouting in the Denervated Striatum of Young Mice: Model of Aging and Neurodegenerative Disease , 1998 .

[27]  J. Bennedsen,et al.  For activated macrophages. , 1979 .

[28]  S. Rayport,et al.  D1- AND D2-like dopamine receptors are co-localized on the presynaptic varicosities of striatal and nucleus accumbens neurons in vitro , 1999, Neuroscience.

[29]  O. Hornykiewicz,et al.  Parkinson's disease and the adaptive capacity of the nigrostriatal dopamine system: possible neurochemical mechanisms. , 1993, Advances in neurology.

[30]  J. Adams.  Heavy metal intensification of DAB-based HRP reaction product. , 1981, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[31]  D L Price,et al.  Localization of D1 and D2 dopamine receptors in brain with subtype-specific antibodies. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[32]  C V Howard,et al.  The total number of neurons in the human neocortex unbiasedly estimated using optical disectors , 1990, Journal of microscopy.

[33]  Y. Agid,et al.  Long‐Term Induction of Tyrosine Hydroxylase Expression: Compensatory Response to Partial Degeneration of the Dopaminergic Nigrostriatal System in the Rat Brain , 1995, Journal of neurochemistry.

[34]  R. Coggeshall,et al.  Erratum: Commentary: Methods for determining numbers of cells and synapses: A case for more uniform standards of review (Journal of Comparative Neurology (1996) 364 (6-15)) , 1996 .

[35]  M. Horne,et al.  The Role of Dopamine Receptors in Regulating the Size of Axonal Arbors , 2001, The Journal of Neuroscience.

[36]  M. Alexander,et al.  Principles of Neural Science , 1981 .

[37]  T. Berger,et al.  Effects of intraventricular 6-hydroxydopamine on the dopaminergic innervation of striatum: Histochemical and neurochemical analysis , 1986, Brain Research.

[38]  Y. Agid,et al.  Hyperactivity of remaining dopaminergic neurones after partial destruction of the nigro-striatal dopaminergic system in the rat. , 1973, Nature: New biology.

[39]  Y. Naum,et al.  Growth of Pulmonary Alveolar Macrophages in vitro , 1973, Nature.

[40]  M. Horne,et al.  The role of dopamine receptors in regulating the size of axonal arbors. , 2001, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[41]  R. Wurtman,et al.  Partial lesions of the dopaminergic nigrostriatal system in rat brain: biochemical characterization , 1980, Brain Research.

[42]  A. Saiardi,et al.  Parkinsonian-like locomotor impairment in mice lacking dopamine D2 receptors , 1995, Nature.

[43]  P. Goldman-Rakic,et al.  An astroglia-linked dopamine D2-receptor action in prefrontal cortex. , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[44]  R. Coggeshall,et al.  Methods for determining numbers of cells and synapses: A case for more uniform standards of review , 1996, The Journal of comparative neurology.

[45]  M. Horne,et al.  Sprouting of Dopaminergic Axons after Striatal Injury: Confirmation by Markers Not Dependent on Dopamine Metabolism , 1999, Experimental Neurology.

[46]  D. Accili,et al.  Dopamine Receptors and Dopamine Transporter in Brain Function and Addictive Behaviors: Insights from Targeted Mouse Mutants , 1998, Developmental Neuroscience.

[47]  O Rascol.  A five-year study of the incidence of dyskinesia in patients with early Parkinson's disease who were treated with ropinirole or levodopa. 056 Study Group , 2000 .

[48]  M. Horne,et al.  Axonal sprouting following lesions of the rat substantia nigra , 2000, Neuroscience.